Kleinjans J C, Smits J F, Kasbergen C M, Vervoort-Peters H T, Struyker Boudier H A
Clin Sci (Lond). 1983 Aug;65(2):111-6. doi: 10.1042/cs0650111.
Sodium chloride solution (0.9%) or noradrenaline in doses of 4, 12 and 36 micrograms h-1 kg-1 was infused for five consecutive days, either intrarenally (by a new technique) or intravenously into rats with one kidney removed. Intrarenal infusion of noradrenaline caused hypertension at doses which did not do so when infused intravenously. Intrarenal compared with intravenous infusion of noradrenaline caused higher plasma noradrenaline concentrations and a shift of the plasma noradrenaline concentration-blood pressure effect curve towards lower plasma noradrenaline levels. These results suggest that hypertension after chronic intrarenal noradrenaline infusion is produced by relatively higher levels of circulating noradrenaline and by triggering of an additional intrarenal pressor mechanism.
将0.9%的氯化钠溶液或剂量为4、12和36微克/小时·千克⁻¹的去甲肾上腺素连续五天通过肾内注射(采用一种新技术)或静脉注射的方式注入一侧肾脏已被摘除的大鼠体内。肾内注射去甲肾上腺素在一定剂量下会导致高血压,而静脉注射相同剂量则不会。与静脉注射相比,肾内注射去甲肾上腺素会使血浆去甲肾上腺素浓度更高,并且使血浆去甲肾上腺素浓度-血压效应曲线向更低的血浆去甲肾上腺素水平偏移。这些结果表明,长期肾内注射去甲肾上腺素后引发的高血压是由循环中相对较高水平的去甲肾上腺素以及触发额外的肾内升压机制所致。